About
Savran Technologies develops a non-invasive urine test that predicts preeclampsia early in pregnancy to enable timely clinical intervention and improve maternal and neonatal outcomes.
Explore Savran Technologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.